Companies
Thriva
offers mail-in finger-prick blood test kits, competing in a UK market that also includes rivals such as Medichecks and Forth, reflecting an established, multi-player consumer category.
- Country
- United Kingdom
Commercial
Mail-in finger-prick blood test kits
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Raised a total of $14.1M to $17.1M across 5 funding rounds | thecompanycheck.com |
| Capacity | Current capacity is 100,000 kits per month, scalable to 500,000 with commitment | thriva.co |
| Certification | Uses UKAS-accredited laboratories (ISO 15189:2022) and maintains ISO 13485-aligned quality management systems for assembly and fulfilment | thriva.co · finishingline.co.uk |
| Regulatory approval | Utilizes NHS-approved workflows and GMC doctor oversight | thriva.co |
| Production site | Fulfilment operations managed by a partner in the UK | finishingline.co.uk |
| Revenue | Estimated annual revenue ranges from $2M to $102.4M across various reports medium confidence | thecompanycheck.com |
Independent sources: finishingline.co.uk · thecompanycheck.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Home blood-analysis kits | diagnostics-medtech | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.